Anders Friberg

Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design

Anders Friberg, Dominico Vigil, Bin Zhao et al. · Journal of Medicinal Chemistry · 2012 · 302 citations · Full text

Lead Compounds, Drug Target, Large Fragment Library +16

The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies

Sven Christian, Claudia Merz, Laura Evans et al. · Leukemia · 2019 · 232 citations · Full text

Mixed-phenotype Acute Leukemia, Genetics, Pathology +17

Discovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods

Nicholas F. Pelz, Zhiguo Bian, Bin Zhao et al. · Journal of Medicinal Chemistry · 2016 · 143 citations · Full text

Drug Target, Molecular Biology, Tumor Biology +16

Discovery of Tricyclic Indoles That Potently Inhibit Mcl-1 Using Fragment-Based Methods and Structure-Based Design

Jason P. Burke, Zhiguo Bian, Subrata Shaw et al. · Journal of Medicinal Chemistry · 2015 · 95 citations · Full text

Combinatorial Chemistry, Drug Target, Molecular Biology +18

Structure and Ligand Binding of the Extended Tudor Domain of D. melanogaster Tudor-SN

Anders Friberg, Lorenzo Corsini, André Mourão et al. · Journal of Molecular Biology · 2009 · 64 citations

Molecular Recognition, D. Melanogaster Tudor-sn, Bioorganic Chemistry +7